These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 4393950)

  • 21. Effect of o-2-hydroxy-3-(tert.-butylamino) propoxybenzonitrile HCl (KO 1366) on beta adrenergic receptors in the cardiovascular system.
    Nayler WG; Tay J
    J Pharmacol Exp Ther; 1972 Feb; 180(2):302-16. PubMed ID: 4400889
    [No Abstract]   [Full Text] [Related]  

  • 22. Trasicor: review of the pharmacology and clinical results.
    Fuccella LM
    S Afr Med J; 1969 Dec; ():Suppl:7-14. PubMed ID: 4190429
    [No Abstract]   [Full Text] [Related]  

  • 23. Structure-selectivity relationships of beta-adrenoceptor antagonists in cats.
    Zakhari S
    Eur J Pharmacol; 1974 Nov; 29(1):22-9. PubMed ID: 4154860
    [No Abstract]   [Full Text] [Related]  

  • 24. Effects of beta-adrenoceptor blocking drugs on the chronotropic and inotropic actions of isoprenaline on the acutely denervated dog heart.
    Harry JD; Kappagoda CT; Linden RJ; Snow HM
    Br J Pharmacol; 1971 Feb; 41(2):387P-389P. PubMed ID: 4396704
    [No Abstract]   [Full Text] [Related]  

  • 25. The selective beta receptor blocking properties of DL-1-(2-acetyl-4-n-butyramidophenoxy)-2-hydroxy-3-isopropylaminopropane HC1 (M & B 17803-A) in the anesthetized dog.
    Levy B
    J Pharmacol Exp Ther; 1973 Jul; 186(1):134-44. PubMed ID: 4146701
    [No Abstract]   [Full Text] [Related]  

  • 26. Pulmonary vascular and cardiac effects of glucagon before and after adrenergic beta-receptor blockade.
    Madan BR; Gupta RS; Jain BK
    Indian J Physiol Pharmacol; 1971 Oct; 15(4):173-7. PubMed ID: 4401547
    [No Abstract]   [Full Text] [Related]  

  • 27. Reversible adrenergic alpha-receptor blocking action of 2,4'-dimethyl-3-piperidino-propiophenone (tolperisone).
    Furuta Y; Yoshikawa A
    Jpn J Pharmacol; 1976 Oct; 26(5):543-50. PubMed ID: 12392
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Studies of 1-(o-cyclopropylphenoxy)-3-isopropylamino-2-propanol, a new -adrenergic blocking drug.
    Boissier JR; Giudicelli JF; Viars P; Advenier C; Mouille P; Larno S
    Eur J Pharmacol; 1971 Jul; 15(2):151-9. PubMed ID: 4403548
    [No Abstract]   [Full Text] [Related]  

  • 29. Beta-adrenoceptor antagonist activity of 3-methoxyisoprenaline.
    Bassett JR
    Br J Pharmacol; 1971 Jan; 41(1):113-21. PubMed ID: 4396127
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of cyclic AMP, sympathomimetic amines, and adrenergic receptor antagonists on renin secretion.
    Winer N; Chokshi DS; Walkenhorst WG
    Circ Res; 1971 Sep; 29(3):239-48. PubMed ID: 4398414
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of 4-(2-hydroxy-3-isopropylaminopropoxy) acetanilide (AY 21,011) on the myocardial and coronary vascular responses to adrenergic stimulation.
    Lucchesi BR; Hodgeman RJ
    J Pharmacol Exp Ther; 1971 Jan; 176(1):200-11. PubMed ID: 4398216
    [No Abstract]   [Full Text] [Related]  

  • 32. Opposite effects of amiodarone and -blocking agents on cardiac function under adrenergic stimulation.
    Charlier R; Delaunois G; Bauthier J
    Arzneimittelforschung; 1972 Mar; 22(3):545-52. PubMed ID: 4402603
    [No Abstract]   [Full Text] [Related]  

  • 33. Oral -adrenoreceptor blocking activity of bunolol and its optical isomers.
    Kaplan HR; Lasala SA; Robson RD
    Eur J Pharmacol; 1971 Oct; 16(2):237-40. PubMed ID: 4405784
    [No Abstract]   [Full Text] [Related]  

  • 34. Evaluation of the pharmacologic basis for the therapy of circulatory shock.
    Moran NC
    Am J Cardiol; 1970 Dec; 26(6):570-7. PubMed ID: 4398718
    [No Abstract]   [Full Text] [Related]  

  • 35. Positive and negative chronotropic response of the S-A node to oxyfedrine.
    Sakai K; Akima M; Sugano S; Shiraki Y
    Jpn J Pharmacol; 1975 Oct; 25(5):573-81. PubMed ID: 1221139
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A potent beta-adrenoreceptor blocking drug: 4-(2-hydroxy-3-isopropylaminopropoxy)indole.
    Moore GE; O'Donnell SR
    J Pharm Pharmacol; 1970 Mar; 22(3):180-8. PubMed ID: 4399485
    [No Abstract]   [Full Text] [Related]  

  • 37. Blockade of cardiac effects of isoproterenol by the stereoisomers of sotalol.
    Somani P; Bachand T
    Eur J Pharmacol; 1969 Sep; 7(3):239-47. PubMed ID: 4390869
    [No Abstract]   [Full Text] [Related]  

  • 38. Effects of beta-blocking agent Ko 592 in massive doses upon catecholamines in arterial tissue and plasma and peripheral blood flow in anesthetized dogs before and after electric stimulation of sympathetic ganglia.
    Terry EN; Clauss RH; Redisch W; Rouen L
    J Cardiovasc Surg (Torino); 1970; 11(2):146-50. PubMed ID: 4394166
    [No Abstract]   [Full Text] [Related]  

  • 39. Comparison of beta-adrenergic blocking effect of DCI, methoxamine, propranolol, MJ 1999, H 56-28, LB 46 and I.C.I. 50 172 on the chronotropic response to isoprenaline.
    Okuda K; Chiba S; Taira N; Hashimoto K
    Jpn J Pharmacol; 1970 Jun; 20(2):294-304. PubMed ID: 4393949
    [No Abstract]   [Full Text] [Related]  

  • 40. The use of Doppler ultrasound techniques to study the effects of isoprenaline and beta-adrenoceptor blocking drugs on peripheral blood vessels in man.
    Fitzgerald DE; Harry JD
    Br J Clin Pharmacol; 1984 Jun; 17(6):773-6. PubMed ID: 6146331
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.